scAtria single-cell spatial atlas resource

NSCLC_38242124 · IMC / Imaging Mass Cytometry

NSCLC_38242124 · NSCLC_38242124__IMC

IMC / Imaging Mass Cytometry Spatial proteomics Curated Tiered

Spatial Domain (Tier 1)

1,001-1,050 of 2,070
Download spatial tables

Spatial Domain (Tier 1)

Dominant neighborhood compartment and purity from Tier 1 domain summaries.

2,069 ready
Sample Organ Disease state Cells Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. Domain share Purity Diversity
NSCLC_38242124__IMC__178_B8,7 Lung Primary cancer 2,258 Tumor/Malignant 59.5% 0.97 0.13
NSCLC_38242124__IMC__178_B8,8 Lung Primary cancer 3,572 Tumor/Malignant 54.8% 0.94 0.19
NSCLC_38242124__IMC__178_B8,9 Lung Primary cancer 2,029 Tumor/Malignant 61.1% 1.00 0.02
NSCLC_38242124__IMC__178_C1,1 Lung Primary cancer 3,156 Tumor/Malignant 55.7% 0.88 0.33
NSCLC_38242124__IMC__178_C1,10 Lung Primary cancer 427 Stromal 37.7% 0.94 0.15
NSCLC_38242124__IMC__178_C1,13 Lung Primary cancer 2,871 Tumor/Malignant 33.0% 0.97 0.12
NSCLC_38242124__IMC__178_C1,14 Lung Primary cancer 820 Stromal 31.6% 0.75 0.53
NSCLC_38242124__IMC__178_C1,15 Lung Primary cancer 1,425 Other 37.8% 0.83 0.41
NSCLC_38242124__IMC__178_C1,16 Lung Primary cancer 833 Other 37.3% 0.74 0.56
NSCLC_38242124__IMC__178_C1,17 Lung Primary cancer 5,784 Immune 76.9% 0.99 0.03
NSCLC_38242124__IMC__178_C1,18 Lung Primary cancer 296 Tumor/Malignant 54.7% 0.80 0.40
NSCLC_38242124__IMC__178_C1,2 Lung Primary cancer 2,430 Tumor/Malignant 37.2% 0.83 0.44
NSCLC_38242124__IMC__178_C1,3 Lung Primary cancer 2,911 Tumor/Malignant 45.1% 0.95 0.18
NSCLC_38242124__IMC__178_C1,6 Lung Primary cancer 20 Other 90.0% 0.50 0.83
NSCLC_38242124__IMC__178_C1,7 Lung Primary cancer 2,737 Other 27.3% 0.69 0.62
NSCLC_38242124__IMC__178_C1,8 Lung Primary cancer 1,107 Stromal 46.2% 0.80 0.48
NSCLC_38242124__IMC__178_C1,9 Lung Primary cancer 799 Stromal 31.2% 0.46 0.74
NSCLC_38242124__IMC__178_C2,1 Lung Primary cancer 1,847 Tumor/Malignant 41.9% 0.91 0.29
NSCLC_38242124__IMC__178_C2,10 Lung Primary cancer 3,482 Immune 28.6% 0.95 0.19
NSCLC_38242124__IMC__178_C2,11 Lung Primary cancer 3,801 Tumor/Malignant 46.1% 0.94 0.20
NSCLC_38242124__IMC__178_C2,13 Lung Primary cancer 3,017 Tumor/Malignant 59.2% 0.95 0.16
NSCLC_38242124__IMC__178_C2,14 Lung Primary cancer 648 Stromal 50.2% 1.00 0.05
NSCLC_38242124__IMC__178_C2,15 Lung Primary cancer 513 Stromal 39.4% 0.40 0.95
NSCLC_38242124__IMC__178_C2,16 Lung Primary cancer 1,161 Tumor/Malignant 35.0% 0.58 0.74
NSCLC_38242124__IMC__178_C2,17 Lung Primary cancer 4,878 Immune 72.8% 0.91 0.23
NSCLC_38242124__IMC__178_C2,3 Lung Primary cancer 1,462 Tumor/Malignant 58.6% 0.96 0.13
NSCLC_38242124__IMC__178_C2,4 Lung Primary cancer 2,930 Tumor/Malignant 59.6% 0.94 0.22
NSCLC_38242124__IMC__178_C2,5 Lung Primary cancer 2,052 Stromal 39.5% 0.86 0.37
NSCLC_38242124__IMC__178_C2,7 Lung Primary cancer 2,504 Other 30.2% 0.56 0.78
NSCLC_38242124__IMC__178_C2,8 Lung Primary cancer 1,063 Stromal 51.6% 0.91 0.26
NSCLC_38242124__IMC__178_C2,9 Lung Primary cancer 1,691 Other 27.7% 0.40 0.89
NSCLC_38242124__IMC__178_C3,1 Lung Primary cancer 491 Tumor/Malignant 31.2% 0.52 0.95
NSCLC_38242124__IMC__178_C3,10 Lung Primary cancer 3,872 Tumor/Malignant 31.2% 0.54 0.64
NSCLC_38242124__IMC__178_C3,12 Lung Primary cancer 1,491 Stromal 31.4% 0.79 0.51
NSCLC_38242124__IMC__178_C3,13 Lung Primary cancer 1,139 Stromal 36.4% 0.82 0.47
NSCLC_38242124__IMC__178_C3,14 Lung Primary cancer 1,703 Stromal 89.3% 1.00 0.02
NSCLC_38242124__IMC__178_C3,17 Lung Primary cancer 5,795 Immune 87.9% 0.99 0.03
NSCLC_38242124__IMC__178_C3,18 Lung Primary cancer 4,246 Tumor/Malignant 84.4% 0.99 0.03
NSCLC_38242124__IMC__178_C3,2 Lung Primary cancer 403 Tumor/Malignant 51.9% 0.88 0.34
NSCLC_38242124__IMC__178_C3,4 Lung Primary cancer 4,062 Stromal 34.5% 0.76 0.47
NSCLC_38242124__IMC__178_C3,5 Lung Primary cancer 3,214 Immune 33.5% 0.89 0.33
NSCLC_38242124__IMC__178_C3,6 Lung Primary cancer 1,618 Immune 37.0% 0.88 0.36
NSCLC_38242124__IMC__178_C3,7 Lung Primary cancer 3,626 Tumor/Malignant 40.8% 0.76 0.57
NSCLC_38242124__IMC__178_C4,1 Lung Primary cancer 3,180 Immune 41.6% 0.78 0.51
NSCLC_38242124__IMC__178_C4,11 Lung Primary cancer 1,793 Stromal 36.8% 0.68 0.66
NSCLC_38242124__IMC__178_C4,12 Lung Primary cancer 2,303 Tumor/Malignant 44.9% 0.90 0.37
NSCLC_38242124__IMC__178_C4,14 Lung Primary cancer 2,709 Stromal 27.8% 0.49 0.85
NSCLC_38242124__IMC__178_C4,15 Lung Primary cancer 69 Other 81.2% 0.52 0.67
NSCLC_38242124__IMC__178_C4,17 Lung Primary cancer 3,857 Immune 63.9% 0.97 0.10
NSCLC_38242124__IMC__178_C4,18 Lung Primary cancer 3,117 Stromal 69.5% 0.99 0.08